A0161 - A phase I study of intravesical camrelizumab for BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC)

Autor: Wang, Y., Xu, P.H., Bian, X.J., Lu, X.L., Wang, Z., Wang, X., Yao, X.D., Shen, Y.J., Ye, D.Y.
Zdroj: In European Urology February 2022 81 Supplement 1:S251-S251
Databáze: ScienceDirect